Clinical Trial Update: Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update assessing the combination of pembrolizumab and lenvatinib in patients with anaplastic thyroid cancer; the study is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Thyroid Cancer

Drugs mentioned

• Lenvatinib (lenvatinib)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Saint Petersburg State University, Russia | Conditions: Anaplastic Thyroid Cancer | Phase 2 | Status: RECRUITING